Nuclear Medicine and Biology
Volume 36, Issue 2 , Pages 199-205 , February 2009

Clinical evaluation of antimicrobial peptide [99mTc/Tricine/HYNIC0]ubiquicidin 29–41 as a human-specific infection imaging agent

  • Mostafa Gandomkar

      Affiliations

    • Nuclear Science Research School, Nuclear Science and Technology Research Institute, Atomic Energy Organization of Iran, Tehran, 11365-3486, Iran
    • Corresponding Author InformationCorresponding author. Tel.: + 98 21 88221097; fax: +98 21 88021412.
    • ,
  • Reza Najafi

      Affiliations

    • Nuclear Science Research School, Nuclear Science and Technology Research Institute, Atomic Energy Organization of Iran, Tehran, 11365-3486, Iran
    • ,
  • Mohammad Shafiei

      Affiliations

    • Nuclear Science Research School, Nuclear Science and Technology Research Institute, Atomic Energy Organization of Iran, Tehran, 11365-3486, Iran
    • ,
  • Mohammad Mazidi

      Affiliations

    • Nuclear Science Research School, Nuclear Science and Technology Research Institute, Atomic Energy Organization of Iran, Tehran, 11365-3486, Iran
    • ,
  • Mostafa Goudarzi

      Affiliations

    • Nuclear Science Research School, Nuclear Science and Technology Research Institute, Atomic Energy Organization of Iran, Tehran, 11365-3486, Iran
    • ,
  • Seyed Hassan Mirfallah

      Affiliations

    • Nuclear Science Research School, Nuclear Science and Technology Research Institute, Atomic Energy Organization of Iran, Tehran, 11365-3486, Iran
    • ,
  • Farhad Ebrahimi

      Affiliations

    • Noor Institute of Nuclear Medicine, Tehran, Iran
    • ,
  • Hamid Reza Heydarpor

      Affiliations

    • Noor Institute of Nuclear Medicine, Tehran, Iran
    • ,
  • Noroz Abdie

      Affiliations

    • Noor Institute of Nuclear Medicine, Tehran, Iran

Received 26 August 2008 ,Revised 27 October 2008 ,Accepted 11 November 2008.

References 

  1. Knight LC. Non-oncologic applications of radiolabeled peptides in nuclear medicine. Q J Nucl Med. 2003;47:279–291
  2. Weiner RE, Thakur ML. Radiolabeled peptides in diagnosis and therapy. Semin Nucl Med. 2001;31:296–311
  3. Fischman AJ, Rauh D, Solomon H, Babich JW, Tompkins RG, Kroon D, et al. In vivo bioactivity and biodistribution of chemotactic peptide analogs in nonhuman primates. J Nucl Med. 1993;34:2130–2134
  4. Vinjamuri S, Hall AV, Solanki KK, Bomanji J, Siraj Q, O’Shaughnessy E, et al. Comparison of 99mTc Infecton imaging with radiolabelled white-cell imaging in the evaluation of bacterial infection. Lancet. 1996;347:233–235
  5. Yapar Z, Kibar M, Yapar AF, Togrul E, Kayaselcuk U, Sarpel Y. The efficacy of technetium-99m ciprofloxacin (Infecton) imaging in suspected orthopaedic infection: a comparison with sequential bone/gallium imaging. Eur J Nucl Med. 2001;28:822–830
  6. Larikka MJ, Ahonen AK, Niemela O, Junila JA, Hamalainen MM, Britton K, et al. Comparison of 99mTc ciprofloxacin, 99mTc white blood cell and three-phase bone imaging in the diagnosis of hip prosthesis infections: improved diagnostic accuracy with extended imaging time. Nucl Med Commun. 2002;23:655–661
  7. Dumarey N, Blocklet D, Appelboom T, Tant L, Schoutens A. Infecton is not specific for bacterial osteo-articular infective pathology. Eur J Nucl Med Mol Imaging. 2002;29:530–535
  8. Sarda L, Saleh-Mghir A, Peker C, Meulemans A, Cremieux AC, Le Guludec D. Evaluation of 99mTc-ciprofloxacin scintigraphy in a rabbit model of Staphylococcus aureus prosthetic joint infection. J Nucl Med. 2002;43:239–245
  9. Sarda L, Cremieux AC, Lebellec Y, Meulemans A, Lebtahi R, Hayem G, et al. Inability of 99mTc-ciprofloxacin scintigraphy to discriminate between septic and sterile osteoarticular diseases. J Nucl Med. 2003;44:920–926
  10. Appelboom T, Emery P, Tant L, Dumarey N, Schoutens A. Evaluation of technetium-99m-ciprofloxacin (Infecton) for detecting sites of inflammation in arthritis. Rheumatology (Oxford). 2003;42:1179–1182
  11. Welling M, Paulusma-Annema A, Balter HS, Pauwels EKJ, Nibbering PH. Technetium-99m labelled antimicrobial peptides discriminate between bacterial infections and sterile inflammations. Eur J Nucl Med. 2000;27:291–301
  12. Nibbering PH, Welling M, Broek VD, Pauwels EKJ. Radiolabelled antimicrobial peptides for imaging of infections: a review. Nucl Med Commun. 1998;19:1117–1121
  13. Welling M, Monguera S, Lupetti A, Balter HS, Bonetto V, Mazzi U, et al. Radiochemical and biological characteristics of 99mTc-UBI 29–41 for imaging of bacterial infections. Nucl Med Biol. 2002;29:413–422
  14. Ferro-Flores G, Arteaga de Murphy C, Pedraza-Lopez M, Melendez-Alafort L, Zhang YM, Rusckowski M, et al. In vitro and in vivo assessment of 99mTc-UBI specificity for bacteria. Nucl Med Biol. 2003;30:597–603
  15. Welling MM, Lupetti A, Balter HS, Lanzzeri S, Souto B, Rey AM, et al. 99mTc-labeled antimicrobial peptides for detection of bacterial and Candida albicans infections. J Nucl Med. 2001;42:788–794
  16. Welling MM, Visentin R, Feitsma HI, Lupetti A, Pauwels EK, Nibbering PH. Infection detection in mice using 99mTc-labeled HYNIC and N2S2 chelate conjugated to the antimicrobial peptide UBI 29–41. Nucl Med Biol. 2004;31:503–509
  17. Welling MM, Korsak A, Gorska B, Oliver P, Mikolajczak R, Balter HS, et al. Kit with technetium-99m labelled antimicrobial peptide UBI 29–41 for specific infection detection. J Label Compd Radiopharm. 2005;48:683–691
  18. Melendez-Alafort L, Rodriguez-Cortes J, Ferro-Flores G, Arteaga De Murphy C, Herrera-Rodriguez R, Mitsoura E, et al. Biokinetics of 99mTc-UBI 29–41 in humans. Nucl Med Biol. 2004;31:373–379
  19. Akhtar MS, Qaisar A, Irfanullah J, Iqbal J, Khan B, Jehangir M, et al. Antimicrobial peptide 99mTc-ubiquicidin 29–41 as human infection imaging agent: clinical trial. J Nucl Med. 2005;46:567–573
  20. Gandomkar M, Najafi R, Shafiei M, Mazidi M, Ebrahimi SES. Preclinical evaluation of [99mTc/EDDA/tricine/HYNIC0, 1-Nal3, Thr8]-octreotide as a new analogue in the detection of somatostatin-receptor-positive tumors. Nucl Med Biol. 2007;34:651–657
  21. Lupetti A, Welling MM, Pauwels EKJ, Nibbering PH. Radiolabelled antimicrobial peptides for infection detection. Lancet Infect Dis. 2003;3:223–229

PII: S0969-8051(08)00243-6

doi: 10.1016/j.nucmedbio.2008.11.003

Nuclear Medicine and Biology
Volume 36, Issue 2 , Pages 199-205 , February 2009

Article Tools

* Image Usage & Resolution